TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 4.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 5.90nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 6.80nMAssay Description:Inhibition of the uptake of tritiated dopamine (DA) in rat synaptosomesMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of the uptake of tritiated dopamine (DA) in rat synaptosomesMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 235nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 265nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 392nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 453nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 629nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.08E+3nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair